Enable Injections, Inc.

10:45 AM - 11:00 AM, Thursday, June 6, 2019 ・ Theater 2
Title: Enabling a Patient-Centered Approach: Large-Volume On-Body Infusors The advancement in drug delivery device and formulation technology is opening up new opportunities for pharmaceutical companies to shift the current treatment paradigm for many patients. Cincinnati-based Enable Injections is an investigational-stage company developing and manufacturing on-body subcutaneous infusion systems for combination products designed to help improve patient quality of life. Enable’s body-worn enFuse™ drug delivery platform utilizes any standard container closure system to deliver large-volume, high-viscosity pharmaceutical and biopharmaceutical therapeutics. The enFuse is designed to 1) be patient-friendly and improve the patient experience, 2) shift the treatments from hospital infusion clinics into the home, 3) improve patient adherence. The Enable Injections enFuse On-Body Platform differentiate's pharmaceutical portfolios and empowers patients to achieve improved outcomes
Ticker:
Not Provided.
Exchange:
Not Provided.
Company Type:
Company HQ State:
Ohio
Company HQ Country:
United States
Year Founded:
2010
Main Therapeutic Focus:
Lead Product in Development:
enFuse On-Body Infusor
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided.
Speaker
photo
VP, Alliance Management and Business Development
Enable Injections, Inc.